Detalhe da pesquisa
1.
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus.
Acta Derm Venereol
; 103: adv12314, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982727
2.
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Clin Exp Dermatol
; 48(9): 991-997, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098171
3.
Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab.
Dermatol Ther
; 35(11): e15835, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114755
4.
Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA index.
Contact Dermatitis
; 84(6): 395-406, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534191
5.
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
Contact Dermatitis
; 2021 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729576
6.
Trend of relevant contact allergens of the feet in Spain over a period of 10 years.
Contact Dermatitis
; 82(4): 211-217, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31625171
7.
European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis.
Contact Dermatitis
; 80(5): 263-272, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520058
8.
Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015).
Contact Dermatitis
; 80(2): 94-100, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30430587
9.
The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: a cross-sectional study.
J Am Acad Dermatol
; 71(3): 507-15, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894454
10.
Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain.
Int J Dermatol
; 62(5): 700-706, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495585
11.
Frontal congenital lipoma.
Pediatr Dermatol
; 29(4): 490-4, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-21906151
12.
Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series.
Int J Dermatol
; 61(8): 1029-1033, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731493
13.
Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study.
F1000Res
; 11: 1178, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567685
14.
Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study.
Int J Dermatol
; 59(5): 633-639, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173862
15.
Severe Atopic Dermatitis In Spain: A Real-Life Observational Study.
Ther Clin Risk Manag
; 15: 1393-1401, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819466